Unmet Needs Index — Biopharma Disease Prioritization
Explore unmet medical needs across 2,400+ diseases scored by efficacy gaps, safety burden, and pipeline activity. Built by Convoke for biopharma R&D teams.
Unmet Needs Index — Biopharma Disease Prioritization Introducing the Unmet Needs Index There are thousands of named human diseases, many of which are rare and obscure. Within each disease, there are yet more subsegments of distinct biology that require their own distinct treatments. With so many patients in need of better drugs, it's hard for a drug developer to know which particular problems to focus on. Because this problem space is so immense, drug developers often focus on solving unmet needs that are visible to them. If you read the history of some of our most impactful therapeutics, it i
Explore this link on the map →saved by
related reading
- benchmarks.bio — Agentic AI benchmarks on messy, real-world biological databenchmarks.bio
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Gap Mapgap-map.org
- AlphaProteo generates novel proteins for biology and health research — Google DeepMinddeepmind.google
- the drug landscapegenome-browser-eight.vercel.app
- Elicit: AI for scientific researchelicit.com
- Hippocratic AI | Safest Generative AI Healthcare Agenthippocraticai.com
- Elicit: AI for scientific researchelicit.org
- Systematic integration of biomedical knowledge prioritizes drugs for repurposinggit.dhimmel.com
- The 23andMe Deal - Cremieux Recueilcremieux.xyz
- DNDi – Best science for the most neglecteddndi.org
- Diseased thinking: dissolving questions about disease — LessWronglesswrong.com